Selinexor, Bortezomib, and Dexamethasone for Heavily Pretreated Multiple Myeloma: A Case Series

被引：5

作者：

Magen, Hila ^{[1
,2
]}

Geva, Mika ^{[1
,2
]}

Volchik, Yulia ^{[1
]}

Avigdor, Abraham ^{[1
,2
]}

Nagler, Arnon ^{[1
,2
]}

机构：

[1] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Dept Hematol, Ramat Gan, Israel

[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷 / 12期

关键词：

Heavily treated patients; Hematologic malignancies; Relapsing/refractory multiple myeloma; Selective inhibitor of nuclear export; Treatment response; TOPOISOMERASE-II; ORAL SELINEXOR; NUCLEAR EXPORT; INHIBITION; DIAGNOSIS; CRITERIA; CELLS;

D O I：

10.1016/j.clml.2020.07.016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E947 / E955

页数：9

共 50 条

[31] BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE (BVD) IN HEAVILY PRETREATED MULTIPLE MYELOMA: OLD/NEW IN NOVEL AGENTS' ERA
Cerchione, C.
Catalano, L.
Nappi, D.
Rocco, S.
Palmieri, S.
Pareto, A. E.
Musuraca, G.
Lucchesi, A.
Ronconi, S.
Ceccolini, M.
Cangini, D.
Giannini, M. B.
Di Battista, V.
Simonetti, G.
Ferrari, A.
Bochicchio, M. T.
di Rora, A. Ghelli Luserna
Ghetti, M.
Napolitano, R.
Fontana, M. C.
Padella, A.
Pane, F.
Ferrara, F.
Martinelli, G.
HAEMATOLOGICA, 2020, 105 : S104 - S104
[32] BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE (BVD) IN HEAVILY PRETREATED MULTIPLE MYELOMA: OLD/NEW IN NOVEL AGENTS' ERA
Cerchione, C.
Catalano, L.
Rocco, S.
Palmieri, S.
Nappi, D.
Pareto, A. E.
Ronconi, S.
Ceccolini, M.
Pane, F.
Martinelli, G.
Ferrara, F.
HAEMATOLOGICA, 2019, 104 : 118 - 118
[33] Bendamustine-Bortezomib-Dexamethasone (BVD) in Heavily Pretreated Multiple Myeloma: Old/New in Novel Agents' Era
Cerchione, Claudio
Catalano, Lucio
Martinelli, Giovanni
AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 : S6 - S6
[34] OLD/NEWIN NOVEL AGENTS' ERA: BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE (BVD) IN HEAVILY PRETREATED MULTIPLE MYELOMA
Cerchione, Claudio
Martinelli, Giovanni
Catalano, Lucio
Rocco, Stefano
Palmieri, Salvatore
Nappi, Davide
Pareto, Anna Emanuele
Ronconi, Sonia
Pane, Fabrizio
Ferrara, Felicetto
AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S4 - S5
[35] Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma
Mateos, Maria V.
Gavriatopoulou, Maria
Facon, Thierry
Auner, Holger W.
Leleu, Xavier
Hajek, Roman
Dimopoulos, Meletios A.
Delimpasi, Sosana
Simonova, Maryana
Spicka, Ivan
Pour, Ludek
Kriachok, Iryna
Pylypenko, Halyna
Doronin, Vadim
Usenko, Ganna
Benjamin, Reuben
Dolai, Tuphan K.
Sinha, Dinesh K.
Venner, Christopher P.
Garg, Mamta
Stevens, Don A.
Quach, Hang
Jagannath, Sundar
Moreau, Philippe
Levy, Moshe
Badros, Ashraf Z.
Anderson, Larry D., Jr.
Bahlis, Nizar J.
Cavo, Michele
Chai, Yi
Jeha, Jacqueline
Arazy, Melina
Shah, Jatin
Shacham, Sharon
Kauffman, Michael G.
Richardson, Paul G.
Grosicki, Sebastian
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
[36] Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma
Maria V. Mateos
Maria Gavriatopoulou
Thierry Facon
Holger W. Auner
Xavier Leleu
Roman Hájek
Meletios A. Dimopoulos
Sosana Delimpasi
Maryana Simonova
Ivan Špička
Ludĕk Pour
Iryna Kriachok
Halyna Pylypenko
Vadim Doronin
Ganna Usenko
Reuben Benjamin
Tuphan K. Dolai
Dinesh K. Sinha
Christopher P. Venner
Mamta Garg
Don A. Stevens
Hang Quach
Sundar Jagannath
Philippe Moreau
Moshe Levy
Ashraf Z. Badros
Larry D. Anderson
Nizar J. Bahlis
Michele Cavo
Yi Chai
Jacqueline Jeha
Melina Arazy
Jatin Shah
Sharon Shacham
Michael G. Kauffman
Paul G. Richardson
Sebastian Grosicki
Journal of Hematology & Oncology, 14
[37] Bendamustine-bortezomib-dexamethasone (BVD) in heavily pretreated multiple myeloma: Old/new in novel agents' era.
Cerchione, Claudio
Catalano, Lucio
Nappi, Davide
Pareto, Anna Emanuele
Pane, Fabrizio
Martinelli, Giovanni
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[38] Bendamustine-Bortezomib-Dexamethasone in Heavily Pretreated Multiple Myeloma: Old PLUS New Drugs in NOVEL Agents' Era
Cerchione, Claudio
Catalano, Lucio
Nappi, Davide
Pareto, Emanuele
Pane, Fabrizio
Martinelli, Giovanni
BLOOD, 2021, 138
[39] Effects of Cytogenetic Risk on Outcomes in Multiple Myeloma Treated with Selinexor, Bortezomib, and Dexamethasone (XVd)
Bahlis, Nizar J.
Richard, Shambavi
White, Darrell J.
Grosicki, Sebastian
Chen, Christine
Delimpasi, Sosana
Sutherland, Heather J.
Maslyak, Zvenyslava
Sebag, Michael
Gavriatopoulou, Maria
Lentzsch, Suzanne
Chari, Ajai
Simonova, Maryana
Spicka, Ivan
Kriachok, Iryna
Dimopoulos, Meletios A.
Pylypenko, Halyna
Auner, Holger W.
Leleu, Xavier
Usenko, Ganna
Hajek, Roman
Benjamin, Reuben
Dolai, Tuphan Kanti
Sinha, Dinesh Kumar
Venner, Christopher P.
Garg, Mamta
Stevens, Don
Quach, Hang
Jagannath, Sundar
Moreau, Philippe
Levy, Moshe
Badros, Ashraf Z.
Anderson, Larry D., Jr.
Facon, Thierry
Mateos, Maria-Victoria
Cavo, Michele
De Castro, Andrew
Chai, Yi
Van Domelen, Dane R.
Mishal, Moran
Bentur, Ohad S.
Shah, Jatin
Shacham, Sharon
Kauffman, Michael G.
Richardson, Paul G.
BLOOD, 2021, 138
[40] Selinexor Demonstrates Marked Synergy with Dexamethasone (Sel-Dex) in Preclinical Models and in Patients with Heavily Pretreated Refractory Multiple Myeloma (MM)
Chen, Christine I.
Gutierrez, Martin
Siegel, David S.
Richter, Joshua R.
Wagner-Johnston, Nina
Hofmeister, Craig C.
Berdeja, Jesus G.
Gabrail, Nashat
Baz, Rachid
Mau-Sorensen, Morten
Trudel, Suzanne
Tiedemann, Rodger E.
Kukreti, Vishal
Areethamsirikul, Nuchanan
Azmi, Asfar
Kashyap, Trinayan
Landesman, Yosef
Marshall, Tracey
McCartney, John
Saint-Martin, Jean-Richard
Norori, Sasha
Savona, Michael R.
Rashal, Tami
Carlson, Robert
Mirza, Mansoor R.
Shacham, Sharon
Kauffman, Michael
Reece, Donna E.
BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →